Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis | stella

Learn Find trials matched to me

Learn Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy For Researchers Data Labs ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis | stella

Back to Myasthenia Gravis, Generalized trials

Recruiting

Plain-English translation of NCT06909253 on ClinicalTrials.gov ↗ · Source last updated September 2026 · How we translate trials

Trial locations(11 sites)

Poland

Research Site, Bydgoszcz

Research Site, Gdansk

Research Site, Katowice

Research Site, Krakow

Research Site, L DZ

Key details

Sponsor

AstraZeneca

Enrollment target

~50 participants

Started

May 2025

Primary completion

December 2029

Age range

18 Years and older

Last updated on clinicaltrials.gov in September 2026.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

AstraZeneca Clinical Study Information Center

AstraZeneca

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.

View full record on ClinicalTrials.gov

Follow this trial

Get notified in plain English when this trial's status changes. No account required.